Patents by Inventor Garret D. Figuly

Garret D. Figuly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110269916
    Abstract: An embodiment of the invention is a water soluble chain-extended polyamine product made by a process comprising reacting a multi-arm polyether amine with a bifunctional crosslinker of the formula: X1—R—X2. Another embodiment is a water soluble chain-extended polyamine product made by a process comprising reacting a multi-arm polyether having at least three arms and three electrophilic endgroups with a primary diamine crosslinker of the formula: NH2—R2—NH2, followed by treating of the chain-extended product so as to convert the remaining electrophilic endgroups to amine endgroups. Crosslinking of the chain-extended polyamine products with an oxidized polysaccharide provides useful tissue adhesives with modified elasticity, that provides greater compliance to underlying tissue, and improved stability in aqueous environments.
    Type: Application
    Filed: May 6, 2011
    Publication date: November 3, 2011
    Inventors: Henry Keith Chenault, Garret D. Figuly
  • Patent number: 7960498
    Abstract: An embodiment of the invention is a water soluble chain-extended polyamine product made by a process comprising reacting a multi-arm polyether amine with a bifunctional crosslinker of the formula: X1—R—X2. Another embodiment is a water soluble chain-extended polyamine product made by a process comprising reacting a multi-arm polyether having at least three arms and three electrophilic endgroups with a primary diamine crosslinker of the formula: NH2—R2—NH2, followed by treating of the chain-extended product so as to convert the remaining electrophilic endgroups to amine endgroups. Crosslinking of the chain-extended polyamine products with an oxidized polysaccharide provides useful tissue adhesives with modified elasticity, that provides greater compliance to underlying tissue, and improved stability in aqueous environments.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: June 14, 2011
    Assignee: Actamax Surgical Materials, LLC
    Inventors: Henry Keith Chenault, Garret D. Figuly
  • Publication number: 20110097299
    Abstract: Swellable and degradable microspheres are described. The microspheres are prepared by a process that is reliable and high yielding, and makes use of a low temperature azo initiator, a small molecule chlorinated solvent as the organic phase, and a heat treatment step, and is carried out in absence of a crosslinking agent. The microsphere preparation made using the process is particularly useful as a degradable embolic material.
    Type: Application
    Filed: January 5, 2011
    Publication date: April 28, 2011
    Applicant: E.I. DU PONT DE NEMOURS AND COMPANY
    Inventor: GARRET D. FIGULY
  • Patent number: 7887846
    Abstract: A process for producing microspheres was developed that provides microspheres that are swellable and degradable. The process is reliable and high yielding, and makes use of a low temperature azo initiator, a small molecule chlorinated solvent as the organic phase, and a heat treatment step, and is carried out in absence of a crosslinking agent. The microsphere preparation made using the process is particularly useful as a degradable embolic material.
    Type: Grant
    Filed: August 4, 2008
    Date of Patent: February 15, 2011
    Assignee: E. I. du Pont de Nemours and Company
    Inventor: Garret D. Figuly
  • Publication number: 20110033608
    Abstract: A process for coating water-swellable hydrogel microspheres with various coating materials is described. The coating process described herein is a fluidized bed process, which utilizes inert, cofluidization particles to aid the fluidization of the microspheres. The use of the cofluidization particles increases the efficiency of the coating process and improves the quality of the coating obtained.
    Type: Application
    Filed: March 6, 2009
    Publication date: February 10, 2011
    Applicant: E.I. DU PONT DE NEMOURS AND COMPANY
    Inventors: Garret D. Figuly, Henricus Jacobus Cornelis Gommeren, Guangliang Liu
  • Publication number: 20110009520
    Abstract: Dimensionally stable, shaped articles comprised of dried, aggregated, water-swellable hydrogel microspheres are described. The microspheres are aggregated together without the use of a binding agent. When exposed to an aqueous medium in a container, the dimensionally stable, shaped article swells slowly and disaggregates, forming at least partially swollen hydrogel microspheres, which take the shape of the container. The dimensionally stable, shaped articles disclosed herein have many potential applications, including medical applications such as a medical implant.
    Type: Application
    Filed: March 19, 2009
    Publication date: January 13, 2011
    Inventors: Garret D. Figuly, Surbhi Mahajan
  • Patent number: 7838035
    Abstract: Highly durable occlusions that are useful for embolic treatment were obtained using microspheres having new combined properties of high density, low fracture, high swell capacity, rapid swell, and deformability following swell. These microspheres are provided in a microsphere powder which also has high density and high swell properties, that is prepared using a new process.
    Type: Grant
    Filed: April 5, 2007
    Date of Patent: November 23, 2010
    Assignee: E. I. du Pont de Nemours and Company
    Inventor: Garret D. Figuly
  • Patent number: 7794755
    Abstract: A process for producing microspheres was developed that provides microspheres with new combined properties of high density, low fracture, high swell capacity, rapid swell, and deformability following swell. The process is reliable and high yielding, and makes use of a low temperature azo initiator and a small molecule chlorinated solvent as the organic phase. The microsphere preparation made using the process is particularly useful in medical treatments such as embolization.
    Type: Grant
    Filed: April 5, 2007
    Date of Patent: September 14, 2010
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Garret D. Figuly, Surbhi Mahajan, Rinaldo S. Schiffino
  • Patent number: 7790926
    Abstract: Alpha, omega-difunctional aldaramides, in particular diaminoaldaramides, dihydroxyaldaramides, bis(alkoxycarbonylalkyl)aldaramides, and bis(carboxyalkyl)aldaramides, and processes for preparing the aldaramides are provided.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: September 7, 2010
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Mark Allen Andrews, Henry Keith Chenault, Garret D. Figuly
  • Publication number: 20100112063
    Abstract: A method for extending the gelation time of an oxidized polysaccharide to react with a water-dispersible, multi-arm amine to form a hydrogel is disclosed. The extension of the gelation time is accomplished by using a chemical additive. The method also extends the time for the hydrogel to become tack-free, and may also be used to decrease the degradation time of the hydrogel. The chemical additive reacts with the functional groups of the oxidized polysaccharide or the water-dispersible, multi-arm amine, thereby reducing the number of groups available for crosslinking. The use of the resulting hydrogel for medical and veterinary applications is described.
    Type: Application
    Filed: June 25, 2008
    Publication date: May 6, 2010
    Inventors: Garret D. Figuly, Samuel David Arthur, Robert Ray Burch, Helen S.M. Lu
  • Publication number: 20100086678
    Abstract: Branched end reactants having two or three functional groups at the ends are disclosed. The branched end reactants are used to prepare crosslinked hydrogel tissue adhesives, which have a good balance of mechanical properties in an aqueous environment. Kits comprising the branched end reactants and methods for applying a coating to an anatomical site on tissue of a living organism are also disclosed.
    Type: Application
    Filed: November 27, 2007
    Publication date: April 8, 2010
    Applicant: E.I.DuPont De Nemours and Company
    Inventors: Samuel David Arthur, Garret D. Figuly
  • Publication number: 20090054535
    Abstract: A method for embolization using liquid embolic materials is described. The method comprises the use of two liquid components. The first liquid component is an aqueous solution or dispersion comprising at least one oxidized polysaccharide. The second liquid component is either an aqueous solution or dispersion comprising at least one water-dispersible, multi-arm amine, or a water-dispersible multi-arm amine in the form of a neat liquid. The two components crosslink in situ to form a hydrogel that should act as an effective embolic agent.
    Type: Application
    Filed: August 20, 2008
    Publication date: February 26, 2009
    Inventors: Garret D. Figuly, Llewellyn Bentley Richardson, III
  • Publication number: 20090041850
    Abstract: A process for producing microspheres was developed that provides microspheres that are swellable and degradable. The process is reliable and high yielding, and makes use of a low temperature azo initiator, a small molecule chlorinated solvent as the organic phase, and a heat treatment step, and is carried out in absence of a crosslinking agent. The microsphere preparation made using the process is particularly useful as a degradable embolic material.
    Type: Application
    Filed: August 4, 2008
    Publication date: February 12, 2009
    Inventor: Garret D. Figuly
  • Publication number: 20080177050
    Abstract: Alpha, omega-difunctional aldaramides, in particular diaminoaldaramides, dihydroxyaldaramides, bis(alkoxycarbonylalkyl)aldaramides, and bis(carboxyalkyl)aldaramides, and processes for preparing the aldaramides are provided.
    Type: Application
    Filed: January 31, 2008
    Publication date: July 24, 2008
    Inventors: Mark Allen Andrews, Henry Keith Chenault, Garret D. Figuly
  • Publication number: 20080146768
    Abstract: Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers are disclosed. The processes can be used to form polymers, particularly crosslinked polymers.
    Type: Application
    Filed: January 15, 2008
    Publication date: June 19, 2008
    Inventors: Mark Allen Andrews, Henry Keith Chenault, Garret D. Figuly
  • Patent number: 7351862
    Abstract: Alpha, omega-difunctional aldaramides, in particular diaminoaldaramides, dihydroxyaldaramides, bis(alkoxycarbonylalkyl)aldaramides, and bis(carboxyalkyl)aldaramides, and processes for preparing the aldaramides are provided.
    Type: Grant
    Filed: February 23, 2006
    Date of Patent: April 1, 2008
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Mark Allen Andrews, Henry Keith Chenault, Garret D. Figuly
  • Publication number: 20080004421
    Abstract: An embodiment of the invention is a water soluble chain-extended polyamine product made by a process comprising reacting a multi-arm polyether amine with a bifunctional crosslinker of the formula: X1—R—X2. Another embodiment is a water soluble chain-extended polyamine product made by a process comprising reacting a multi-arm polyether having at least three arms and three electrophilic endgroups with a primary diamine crosslinker of the formula: NH2—R2—NH2, followed by treating of the chain-extended product so as to convert the remaining electrophilic endgroups to amine endgroups. Crosslinking of the chain-extended polyamine products with an oxidized polysaccharide provides useful tissue adhesives with modified elasticity, that provides greater compliance to underlying tissue, and improved stability in aqueous environments.
    Type: Application
    Filed: June 21, 2007
    Publication date: January 3, 2008
    Inventors: Henry Keith Chenault, Garret D. Figuly
  • Publication number: 20070237956
    Abstract: A process for producing microspheres was developed that provides microspheres with new combined properties of high density, low fracture, high swell capacity, rapid swell, and deformability following swell. The process is reliable and high yielding, and makes use of a low temperature azo initiator and a small molecule chlorinated solvent as the organic phase. The microsphere preparation made using the process is particularly useful in medical treatments such as embolization.
    Type: Application
    Filed: April 5, 2007
    Publication date: October 11, 2007
    Inventors: Garret D. Figuly, Surbhi Mahajan, Rinaldo S. Schiffino
  • Publication number: 20070237741
    Abstract: A method for medical treatment was developed in which microspheres with novel properties are administered in a mammal. The microspheres are made using a novel process that results in microspheres with new combined properties of high density, low fracture, high swell capacity, rapid swell, and deformability following swell. These microspheres may be administered for void filling, tissue bulking, non-vasculature occlusion, body fluid absorption, and delivery of medications.
    Type: Application
    Filed: April 5, 2007
    Publication date: October 11, 2007
    Inventors: Garret D. Figuly, Surbhi Mahajan, Rinaldo S. Schiffino, Sujata K. Bhatia, Elazer R. Edelman, Tarek Michael Shazly, Michael Jordan Feldstein
  • Publication number: 20070237830
    Abstract: Highly durable occlusions that are useful for embolic treatment were obtained using microspheres having new combined properties of high density, low fracture, high swell capacity, rapid swell, and deformability following swell. These microspheres are provided in a microsphere powder which also has high density and high swell properties, that is prepared using a new process.
    Type: Application
    Filed: April 5, 2007
    Publication date: October 11, 2007
    Inventor: Garret D. Figuly